Paul Leeson is a medicinal chemistry consultant with >35 years’ experience in major pharmaceutical companies: Smith Kline and French, Merck Sharp and Dohme, Wyeth (USA), AstraZeneca, and GlaxoSmithKline. Since 2014 he has advised pharmaceutical companies, start-ups, and academia. At AstraZeneca (1997-2011) Paul was Head of Medicinal Chemistry at the Charnwood site and led AstraZeneca’s Global Chemistry Forum, holding accountability for the company’s chemistry strategy.


Paul has a PhD from the University of Cambridge and holds an honorary professorship at the University of Nottingham.


Paul’s drug discovery contributions have been in the cardiovascular, neuroscience, respiratory and inflammation therapy areas. He has a special interest in compound quality and in 2014 he received the Nauta Award from the European Federation of Medicinal Chemistry.